KYMR - Kymera Therapeutics, Inc. -  [ ]

Ticker Details
Kymera Therapeutics, Inc.
IPO Date: August 21, 2020
Sector: Healthcare
Industry: Biotech
Market Cap: $9.96B
Activated in VL: True
Average Daily Range
Avg Daily Range: $1.39 | 3.28%
Avg Daily Range (30 D): $2.56 | 2.25%
Avg Daily Range (90 D): $2.54 | 2.62%
Institutional Daily Volume
Avg Daily Volume: .48M
Avg Daily Volume (30 D): .5M
Avg Daily Volume (90 D): .58M
Trade Size
Avg Trade Size (Sh.): 54
Avg Trade Size (Sh.) (30 D): 43
Avg Trade Size (Sh.) (90 D): 47
Institutional Trades
Total Institutional Trades: 2,830
Avg Institutional Trade: $3.12M
Avg Institutional Trade (30 D): $11.46M
Avg Institutional Trade (90 D): $7.27M
Avg Institutional Trade Volume: .07M
Avg Institutional Trades (Per Day): 2
Market Closing Trades
Avg Closing Trade: $4.39M
Avg Closing Trade (30 D): $11.94M
Avg Closing Trade (90 D): $12.31M
Avg Closing Volume: 96.97K
 
News
Jul 12, 2026 @ 8:37 PM
Kymera's CEO Sold $6 Million in Stock After a 170%...
Source: Jonathan Ponciano
Jun 12, 2026 @ 11:00 AM
Kymera Therapeutics Presents Phase 1 Data in Healt...
Source: Na
Jun 8, 2026 @ 11:00 AM
Kymera Therapeutics Presents New Preclinical Lupus...
Source: Kymera Therapeutics
May 15, 2026 @ 11:00 AM
Kymera Therapeutics Announces Presentations on KT-...
Source: Na
May 6, 2026 @ 11:00 AM
Kymera Therapeutics to Participate in Upcoming May...
Source: Not Specified
Financials
  TTM Q2 2026 Q1 2026
Basic EPS $-3.25 $-.62 $-.71
Diluted EPS $-3.25 $-.62 $-.71
Revenue $105M $65M $34.37M
Gross Profit $M $M $M
Net Income / Loss $-299.6M $-61.21M $-69.23M
Operating Income / Loss $-350.18M $-75.61M $-84.16M
Cost of Revenue $105M $65M $34.37M
Net Cash Flow $-211.34M
PE Ratio